Table 2.

Characteristics and Outcomes of Participants (n=58) with a Final Diagnosis of Acetaminophen Toxicity

Age (Years)	n(%)
<1	2(3)
1–2	1(2)
3–9	4(7)
10–17	51(88)
Gender
Female	46(79)
Ethnicity
Hispanic or Latino	5(9)
Race
White	44(77)
African American	5(9)
Other	8(14)
Hepatic Encephalopathy at Enrollment
Grade II or less	51
Grade III or IV	7
Laboratory Value Median (25%– 75%)
Alanine Aminotransferase IU/L (n=55)	5305(3371–7771)
Aspartate Aminotransferase IU/L (n=58)	4053(2022–7605)
Total Bilirubin mg/dL (n=58)	2.2(1.2–3.1)
Direct Bilirubin mg/dL (n=51)	0.6(0.3–1.2)
International Normalized Ratio (n=53)	2.3(1.7–3.7)
Creatinine mg/dL (n=57)	0.7(0.6–1.1)
21 day Outcome
Death without Transplantation	2(3.5%)
Transplantation	3(5.2%)
Spontaneous Survival	53(91.4%)